OAM
EVH icon

Oxford Asset Management’s Evolent Health EVH Stock Holding History

Oxford Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-41,862
Closed -$835K – 1748
2018
Q4 		$835K Buy
+41,862
New +$968K 0.02% 949

Other funds holding EVH

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Oxford Asset Management's EVH Position: Q1 2019 in Review

Oxford Asset Management sold out of Evolent Health (EVH) in Q1 2019, closing a stake of 41,862 shares — an estimated $835K sold.

Oxford Asset Management first reported a position in EVH in Q4 2018 and held it in 1 quarter. The position peaked at $835K in Q4 2018. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2019.

  • Oxford Asset Management reported no remaining Evolent Health position as of Q1 2019 after selling out during the quarter.
  • Oxford Asset Management sold 41,862 Evolent Health shares in Q1 2019, an estimated $835K.
  • Oxford Asset Management first reported a position in Evolent Health in Q4 2018 and held it in 1 quarter.
  • Oxford Asset Management's Evolent Health position peaked at $835K in Q4 2018.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2019.

Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.